Journal of Experimental & Clinical Cancer Research (Jan 2022)

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

  • Ilaria Romito,
  • Manuela Porru,
  • Maria Rita Braghini,
  • Luca Pompili,
  • Nadia Panera,
  • Annalisa Crudele,
  • Daniela Gnani,
  • Cristiano De Stefanis,
  • Marco Scarsella,
  • Silvia Pomella,
  • Stefano Levi Mortera,
  • Emmanuel de Billy,
  • Adrian Libenzio Conti,
  • Valeria Marzano,
  • Lorenza Putignani,
  • Manlio Vinciguerra,
  • Clara Balsano,
  • Anna Pastore,
  • Rossella Rota,
  • Marco Tartaglia,
  • Carlo Leonetti,
  • Anna Alisi

DOI
https://doi.org/10.1186/s13046-022-02247-y
Journal volume & issue
Vol. 41, no. 1
pp. 1 – 6

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.